Pacific Biosciences of California, Inc.(NASDAQ : PACB)
PACB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||0.35%||463.19||2.7%||$534.62m|
|GILD||Gilead Sciences, Inc.||0.20%||64.75||1.0%||$502.19m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.76%||213.58||1.9%||$461.68m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.03%||150.06||2.0%||$329.21m|
|BNGO||BioNano Genomics, Inc.||8.67%||7.77||0.0%||$322.31m|
|CRSP||CRISPR Therapeutics AG||-0.90%||113.62||0.6%||$321.43m|
|EXAS||EXACT Sciences Corp.||-4.17%||116.57||18.4%||$244.18m|
|PACB||Pacific Biosciences of California, Inc.||-6.49%||27.37||7.2%||$176.05m|
Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.